AMANDA SMITH: Open Payments
NPI 1508467010 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 56 payments from 15 companies in 2025. Trend: 2023 $965 · 2024 $487 · 2025 $1,052
Food & beverage: $878Education: $173
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $227 |
| ABBVIE INC. | 16 | $176 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 3 | $113 |
| UCB, Inc. | 3 | $77 |
| Amgen Inc. | 4 | $64 |
| Incyte Corporation | 3 | $63 |
| GENZYME CORPORATION | 3 | $52 |
| Lilly USA, LLC | 2 | $40 |
| Galderma Laboratories, L.P. | 1 | $24 |
Products named: TREMFYA, DUPIXENT, XIFAXAN, RINVOQ, Bimzelx, OTEZLA, OPZELURA, SKYRIZI.
Industry payments across OH — which companies pay providers there.
